Many vs. Cancer: First Major Global Crowd funding Effort to Defeat Prostate Cancer

Many vs. Cancer, the first major global Crowdfunding Initiative to Defeat Prostate Cancer, launched May 17, 2017, with an ambitious program, and a goal to greatly accelerate research into the search for cure. Its strategies are of the moment-- including global crowd funding, through innovative community engagement tools and campaigns. All money raised by any Many vs. Cancer goes directly to the PCF

“Many vs. Cancer represents the final push to defeat prostate cancer once and for all. PCF has raised more than $700 million for prostate cancer research to date, which has resulted in great strides and decreased the death rate in prostate cancer by 53 percent so far, Dr. Simons, MD, President and CEO. He is optimistic. “We are on the cusp of defeating this deadly disease. We know what has to be done to get us to the finish line, and now it’s simply a matter of money.”

All the more promising is the news that the “The defeat of prostate cancer will result in cures for 16 other cancers that have genetic similarities.”

In mid-May, 2017, the Many vs. Cancer Initiative awarded support for a research project led by Matthew Rettig, MD, Professor of Medicine and Oncology and Medical Director of the Prostate Cancer Program at the David Geffen School of Medicine at UCLA. Dr. Rettig accepted this honor, with remarks on the hope and promise of his research effort:  “The work we are doing at UCLA will help researchers create more informed, precision treatment strategies that will improve the quality and extend the lives of those suffering from prostate Cancer.” 

About the Prostate Cancer Foundation

The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization funding and accelerating prostate cancer research. Founded in 1993, PCF has raised more than $700 million and provided funding to more than 2,000 research programs at more than 200 cancer centers and universities. The PCF global research enterprise now extends to 19 countries. PCF advocates for greater awareness of prostate cancer and more efficient investment of government research funds for transformational cancer research. Its efforts have helped produce a 20-fold increase in government funding for prostate cancer.

Written by: Courtney Leonard, a medical writer for UroToday

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.